Source link : https://newshealth.biz/health-news/daraxonrasib-combo-shows-promise-in-first-line-mpdac/
A phase 1/2 trial shows strong early efficacy for daraxonrasib plus chemotherapy as first-line treatment for patients with metastatic pancreatic cancer — but toxicity is a concern. Medscape Medical News Source link : https://www.medscape.com/viewarticle/daraxonrasib-combo-shows-promise-first-line-mpdac-2026a1000d0k?src=rss Author : Publish date : 2026-04-24 06:50:00 Copyright for syndicated content belongs to the linked Source.
The post Daraxonrasib Combo Shows Promise in First-Line mPDAC first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-24 06:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8